☆ 4.0 Article

Accessing three-branched high-affinity cereblon ligands for molecular glue and protein degrader design

RSC CHEMICAL BIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Medicinal

Synthesis of novel glutarimide ligands for the E3 ligase substrate receptor Cereblon (CRBN): Investigation of their binding mode and antiproliferative effects against myeloma cell lines

Mikhail Krasavin et al.

Summary: In order to enhance the chemical toolkit for targeted protein degradation, the authors developed a new series of non-thalidomide Cereblon (CRBN) ligands. By using a thio-Michael addition reaction, readily available 2-methylidene glutarimide was converted to a series of 2-((hetero)aryl(methyl))thio glutarimides. These compounds were evaluated for their affinity to human CRBN and their binding modes were studied through X-ray crystallography. The newly identified Cereblon ligands show promising potential for the synthesis of novel PROTAC protein degraders.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Add to Collection

Article Biochemical Research Methods

High-resolution structures of the bound effectors avadomide (CC-122) and iberdomide (CC-220) highlight advantages and limitations of the MsCI4 soaking system

Christopher Heim et al.

Summary: This study investigated the binding modes of next-generation IMiDs drugs on Cereblon using a crystal-soaking system, providing important insights for the development of future cereblon effectors.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2022)

Add to Collection

Article Chemistry, Medicinal

A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs

Irene Preet Bhela et al.

Summary: The study presents a novel platform that combines multicomponent reactions and protein degraders to prepare highly decorated PROTACs. By applying this platform to BRD4 degradation, a set of degraders with high efficiency was discovered. This approach provides a versatile and cost-effective means to access libraries of protein degraders and increase the chance of identifying successful candidates.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Add to Collection

Article Chemistry, Medicinal

SJPYT-195: A Designed Nuclear Receptor Degrader That Functions as a Molecular Glue Degrader of GSPT1

Andrew D. Huber et al.

Summary: This study describes the discovery of a molecule, SJPYT-195, which can reduce the protein level of PXR by acting as a molecular glue degrader of GSPT1, a translation termination factor. The findings provide insights into the chemical determinants of drug-induced GSPT1 degradation and also present assays and cell models for the discovery of PXR degraders.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Add to Collection

Article Multidisciplinary Sciences

The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron

Saki Ichikawa et al.

Summary: This study identifies C-terminal cyclic imides as physiological degrons for the ubiquitin E3 ligase substrate adapter cereblon (CRBN). The addition of these degrons induces CRBN-dependent ubiquitination and degradation of proteins. This discovery has significant implications for understanding the physiological and therapeutic engagement of CRBN.

NATURE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Identification and structural basis of C-terminal cyclic imides as natural degrons for cereblon

Christopher Heim et al.

Summary: The study found that Cereblon (CRBN) can specifically recognize C-terminal aspartimide and aminoglutarimide residues, which are formed due to chain breaks in aging proteins and may mark potentially dysfunctional protein fragments.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Development of the first non-hydroxamate selective HDAC6 degraders

Tim Keuler et al.

Summary: The development of a new class of selective HDAC6 degraders based on a difluoromethyl-1,3,4-oxadiazole (DFMO) warhead as ZBG is reported, providing a promising approach to treat HDAC6-driven diseases.

CHEMICAL COMMUNICATIONS (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Targeting the deubiquitinase USP7 for degradation with PROTACs

Arunima Murgai et al.

Summary: This study reports a novel approach to degrade USP7 using PROTACs based on a USP7 inhibitor scaffold. A highly selective USP7 degrader compound was discovered, which induced apoptosis in USP7-dependent cancer cells. This work unlocks a new drug target class for protein degradation.

CHEMICAL COMMUNICATIONS (2022)

Add to Collection

Review Chemistry, Multidisciplinary

E3 ligase ligand chemistries: from building blocks to protein degraders

Izidor Sosic et al.

Summary: Proteolysis-targeting chimeras (PROTACs) have shown great therapeutic potential and usefulness as molecular biology tools in recent years. These compounds induce targeted protein degradation by forming a ternary complex and leading to E3 ligase-mediated ubiquitination and proteasomal degradation. The field of PROTAC has grown substantially due to advancements in the discovery of non-peptidic E3 ligase ligands. Expanding the range of E3 ligands could contribute to broadening the scope of targeted protein degradation. This review focuses on the chemistry aspect of PROTAC design and serves as a blueprint for future research in this complex field.

CHEMICAL SOCIETY REVIEWS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

On the correlation of cereblon binding, fluorination and antiangiogenic properties of immunomodulatory drugs

Christopher Heim et al.

Summary: CRBN is the substrate receptor of an E3 ubiquitin ligase complex and a target of thalidomide and its derivatives. The binding of IMiDs to CRBN alters the substrate specificity of the ligase, mediating effects exploited in cancer therapy. The involvement of other possible targets in the efficacy of IMiDs is not clear.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Add to Collection

Article Chemistry, Medicinal

Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay

Samuel Maiwald et al.

Summary: Repurposing E3 ubiquitin ligases for targeted protein degradation via customized molecular glues or PROTACs is important, but limited by our incomplete understanding of E3 ligases and their ligand space. A quantitative assay based on the thermophoretic behavior of a custom reporter ligand offers a potential high-throughput screening method for discovering and characterizing E3 ligase ligands.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Petasis vs. Strecker Amino Acid Synthesis: Convergence, Divergence and Opportunities in Organic Synthesis

Wayiza Masamba

Summary: This review discusses the widespread applications of alpha-amino acids in various areas and compares the differences and similarities between the Petasis and Strecker reactions, two of the most widely used protocols for their synthesis.

MOLECULES (2021)

Add to Collection

Article Chemistry, Medicinal

Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries

Bo Wang et al.

Summary: PROTACs have attracted significant interest in academic and pharmaceutical communities for regulating cellular protein homeostasis. A series of MDM2 degraders were designed and synthesized, with WB214 identified as a potent anti-proliferative agent inducing the degradation of MDM2 and p53. Mechanistic studies revealed that WB214 functions as a molecular glue degrading MDM2, and MDM2 was discovered as a novel neo-substrate of the E3 ligase cereblon. Additionally, WB214 could potently degrade GSPT1, leading to the development of a selective degrader for GSPT1 over MDM2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Chemistry, Medicinal

Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators

Gisele Nishiguchi et al.

Summary: This study describes the design, synthesis, and screening of a large diverse library of thalidomide analogues against leukemia and medulloblastoma cell lines, leading to the discovery of potent GSPT1/2 degraders with selectivity over IMiD neosubstrates and high oral bioavailability in mice. Compound 6 (SJ6986) is proposed as a valuable tool for studying the role of GSPT1/2 and supports the utility of a diverse library of CRBN binders in targeting undruggable oncoproteins.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Acute pharmacological degradation of Helios destabilizes regulatory T cells

Eric S. Wang et al.

Summary: This study developed small molecules that promote Helios degradation, destabilizing the anergic phenotype of T-reg cells and reducing their suppressive activity, providing a framework for targeting Helios therapeutically.

NATURE CHEMICAL BIOLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Room-Temperature Cu(II) Radical-Triggered Alkyne C-H Activation

Jack Devonport et al.

Summary: A dimeric Cu(II) complex was synthesized and characterized, showing a monomeric-dimeric equilibrium in solution. Addition of phenylacetylene led to the formation of a transient radical species, initiating an alkyne C-H bond activation process. The unusual C-H activation method is applicable for efficient synthesis of propargylamines within 16 hours, demonstrating structural stability and redox retention.

JACS AU (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library

Chelsea E. Powell et al.

ACS CHEMICAL BIOLOGY (2020)

Add to Collection

Article Biochemical Research Methods

diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition

Florian Meier et al.

NATURE METHODS (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders

Christian Steinebach et al.

CHEMICAL SCIENCE (2020)

Add to Collection

Article Chemistry, Organic

Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction

Xing Qiu et al.

ORGANIC LETTERS (2019)

Add to Collection

Article Chemistry, Medicinal

De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives

Christopher Heim et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Review Chemistry, Multidisciplinary

Reactivity and Synthetic Applications of Multicomponent Petasis Reactions

Peng Wu et al.

CHEMICAL REVIEWS (2019)

Add to Collection

Article Chemistry, Medicinal

Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer

Xin Han et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Add to Collection

Review Oncology

Mechanism of Action and Novel IMiD-Based Compounds and Combinations in Multiple Myeloma

Ajay K. Nooka et al.

CANCER JOURNAL (2019)

Add to Collection

Article Chemistry, Multidisciplinary

PROTAC-mediated crosstalk between E3 ligases

Christian Steinebach et al.

CHEMICAL COMMUNICATIONS (2019)

Add to Collection

Article Chemistry, Medicinal

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos

Mary E. Matyskiela et al.

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Add to Collection

Review Biotechnology & Applied Microbiology

Chemical probes and drug leads from advances in synthetic planning and methodology

Christopher J. Gerry et al.

NATURE REVIEWS DRUG DISCOVERY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Homo-PROTACs for the Chemical Knockdown of Cereblon

Christian Steinebach et al.

ACS CHEMICAL BIOLOGY (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Chemical Ligand Space of Cereblon

Iuliia Boichenko et al.

ACS OMEGA (2018)

Add to Collection

Article Biochemistry & Molecular Biology

BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment

Georg E. Winter et al.

MOLECULAR CELL (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

Jing Lu et al.

CHEMISTRY & BIOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS

Jan Kroenke et al.

NATURE (2015)

Add to Collection

Article Biochemical Research Methods

Synthesis of BODIPY Derivatives Substituted with Various Bioconjugatable Linker Groups: A Construction Kit for Fluorescent Labeling of Receptor Ligands

Fabian Heisig et al.

JOURNAL OF FLUORESCENCE (2014)

Add to Collection

Article Multidisciplinary Sciences

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

Jan Kroenke et al.

SCIENCE (2014)

Add to Collection

Review Chemistry, Multidisciplinary

Chemistry and Biology Of Multicomponent Reactions

Alexander Domling et al.

CHEMICAL REVIEWS (2012)

Add to Collection

Article Multidisciplinary Sciences

Selective inhibition of BET bromodomains

Panagis Filippakopoulos et al.

NATURE (2010)

Add to Collection

Article Chemistry, Organic

On the use of boronates in the Petasis reaction

H Jourdan et al.

TETRAHEDRON LETTERS (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.